Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail

Current and Emerging Options in the Treatment of Onychomycosis

(2016) Boni Elewski et al.   SEMINARS IN CUTANEOUS MEDICINE AND SURGERY

The Epidemiology, Etiology, and Pathophysiology of Onychomycosis

(2016) Richard Scher et al.   SEMINARS IN CUTANEOUS MEDICINE AND SURGERY

Contact dermatitis caused by efinaconazole solution for treatment of onychomycosis

(2015) Ayaki Hirohata et al.   CONTACT DERMATITIS

Efinaconazole Topical Solution, 10%: Formulation Development Program of a New Topical Treatment of Toenail Onychomycosis

(2015) V. Bhatt et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies

(2015) Boni E. Elewski et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Efinaconazole: Developmental and reproductive toxicity potential of a novel antifungal azole

(2015) M. Glynn et al.   REPRODUCTIVE TOXICOLOGY

In VitroandIn VivoAssessment of Dermatophyte Acquired Resistance to Efinaconazole, a Novel Triazole Antifungal

(2014) Atsushi Iwata et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Low Keratin Affinity of Efinaconazole Contributes to Its Nail Penetration and Fungicidal Activity in Topical Onychomycosis Treatment

(2014) Keita Sugiura et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nonclinical safety assessment of Efinaconazole Solution (10%) for onychomycosis treatment

(2014) William Jo et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Mechanism of Action of Efinaconazole, a Novel Triazole Antifungal Agent

(2013) Yoshiyuki Tatsumi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison ofIn VitroAntifungal Activities of Efinaconazole and Currently Available Antifungal Agents against a Variety of Pathogenic Fungi Associated with Onychomycosis

(2013) William J. Jo Siu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Psychosocial impact of onychomycosis: a review

(2013) Anna Chacon et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis

(2013) Bárður Sigurgeirsson et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study

(2013) Hans-Jürgen Tietz et al.   MYCOSES

Fungicidal Drugs Induce a Common Oxidative-Damage Cellular Death Pathway

(2013) Peter Belenky et al.   Cell Reports

Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies

(2012) Boni E. Elewski et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta-analysis of efficacy for continuous and intermittent regimens

(2012) A.K. Gupta et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Onychomycosis Does Not Always Require Systemic Treatment for Cure: A Trial Using Topical Therapy

(2012) Shiela Fallon Friedlander et al.   PEDIATRIC DERMATOLOGY

A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis

(2011) B. Elewski et al.   BRITISH JOURNAL OF DERMATOLOGY

Systematic review of nondermatophyte mold onychomycosis: Diagnosis, clinical types, epidemiology, and treatment

(2011) Aditya K. Gupta et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Onychomycosis

(2010) Oliverio Welsh et al.   CLINICS IN DERMATOLOGY

REVIEW ARTICLE: Toenail onychomycosis: an important global disease burden

(2010) J. Thomas et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents

(2010) Bianca Maria Piraccini et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY